Drug Repurposing Yields Hope for Reversing Effects of Parkinson’s

Preliminary findings from a small-scale study by Georgetown University Medical Center (GUMC) researchers indicate that a medication approved to treat leukemia may halt or reverse the progression of Parkinson’s disease and Lewy body dementia.

Product Spotlight

A New Frontier in Stroke Telemedicine

Ambulances outfitted with a mobile CT scanner, blood sample laboratory and telemedicine connection decrease the time between stroke and thrombolysis without increasing the risk of complications, according to a study in JAMA.

911 dispatchers ask a...

Redirecting the Debate about Concussions among Soccer Players

For soccer players, reducing the likelihood of concussion goes well beyond avoiding ball heading — a research finding that can inform physicians’ recommendations to players and parents.

Product Spotlight

Injectable Electronic Meshes

A team of Harvard scientists has created 2-by-4-centimeter meshes of silicone nanowires that are so thin and flexible they can be placed in a saline solution, drawn up into a syringe and injected into a living host.

“The meshes rolled up like tiny scrolls...

Combining Treatments to Boost MS Remission Rates

A study by the National Institute of Allergy and Infectious Diseases yielded extended remissions for patients coping with relapsing-remitting multiple sclerosis (RRMS).

Study Questions Value of Transcranial Direct-current Stimulation

Looking for reading material for patients curious about undergoing transcranial electrical brain stimulation to improve their mood or memory? A meta-analysis by Australian researchers may be a good place to start, at least when it comes to answering questions from patients eager to improve cognition. 

Noninvasive Stimulation Shows Promise for Stroke Recovery

Stroke patients who received navigated, repetitive transcranial magnetic stimulation (TMS) in addition to standard occupational therapy (OT) were able to regain and maintain more upper-extremity mobility than those who completed OT alone, a 2014 study found.

That’s News

Autism Risk, Cord Blood for IBD and More 

CenterPointe Hospital Offers TMS Therapy: A New Hope for Patients Diagnosed with Depression

As depression rates in the United States (9 percent of adult Americans) and worldwide are increasing, it’s a certainty that you know someone — or many individuals — diagnosed with clinical depression. 

WVU Healthcare’s Neurointerventional Stroke Care Protocols Optimize Treatment Efficacy and Outcomes

Intravenous recombinant tissue-plasminogen activator (IV rt-PA) has been the standard for stroke treatment since it gained FDA approval in 1996. The neurointerventional program at WVU Healthcare has been utilizing advanced neuro-imaging and endovascular techniques to treat stroke patients who may not respond to IV rt-PA or those who present beyond the IV rt-PA time window. The stroke program has been part of clinical trials affirming the efficacy of endovascular therapy for large-vessel strokes.